We’re helping laboratories tackle two key areas in testing to aid physicians in making a confident diagnosis.
The first is the widespread issue of interferences – substances like biotin that alter routine test results. The second is the difficulty in measuring biomarkers of low abundance.
With our novel nanomagnetic technology, we are moving the needle on what is possible to measure; realizing the potential of low abundance biomarkers and their use in diagnostic tests in the fields of neurology, cardiology, oncology, and bone and mineral.
Rapidly captures potentially damaging interferences, allowing the cleaned sample to be reliably tested using existing methods
Rapidly captures low abundance biomarkers, allowing the enriched sample to be tested using existing methods
Detect the presence of an interference-causing substance in a sample
Pre-treat a sample to remove an interference-causing substance and rule in/out whether it is clinically significant
Veravas’ proprietary sample preparation technology enables the simple, efficient, and cost effective conditioning and characterization of specimens to manage and mitigate a number of known sample interferences prior to the subsequent enrichment of low abundance biomarkers using our 6C’s:
The number of people taking over-the-counter, high-dose biotin supplements for health and cosmetic reasons is growing 20% annually worldwide.1 Biotin-related testing interference is also rising, which puts patients at risk of misdiagnosis, inappropriate patient management,2 or adverse events.3
Rapidly screen samples to identify biotin levels greater than 15 ng/mLLearn More
Proprietary antibody for use as an alternative to anti-biotin antibodies and streptavidin-based reagentsLearn More
Our dedicated team can answer your questions and help you with biotin-interference issues.Contact Us